Skip to main content
. 2023 Apr 11;2023(4):CD013873. doi: 10.1002/14651858.CD013873.pub2

1.18. Analysis.

1.18

Comparison 1: High‐ versus standard‐dose strategies for any indication, Outcome 18: Retinopathy of prematurity (ROP) (severe ROP [stage 3 or greater]) (International Committee 2005)